Learn More
Invitrogen™ Complement C3a Monoclonal Antibody (K13/16-5.7)

Description
GAU 013-16-02 detects Complement Componet C3a/C3a (desArg) in human samples. This antibody does not cross-react with C4a or C5a. GAU 013-16-02 has been successfully used in ELISA and Western blot procedures. GAU 013-16-02 can be used as a capture antibody in sandwich ELISA with GAU 017-01-02 as detection antibody. This antibody detects an epitope that is present on human C3, C3a, and C3a (desArg), but does not cross react with C4a or C5a. NOTE: Concentration is lot-dependent and can vary from 0.85-1.15 mg/mL.
Specifications
Specifications
| Antígeno | Complement C3a |
| Aplicaciones | ELISA, Immunohistochemistry (Paraffin), Western Blot |
| Clasificación | Monoclonal |
| Clon | K13/16-5.7 |
| Concentración | 1.07 mg/mL |
| Conjugado | Unconjugated |
| Formulación | PBS with 15mM sodium azide; pH 7.4 |
| génica | C3 |
| N.º de referencia del gen | P01024 |
| Alias de gen | Acylation stimulating protein; acylation-stimulating protein cleavage product; AHUS5; AI255234; ARMD9; ASP; C3; C3 and PZP-like alpha-2-macroglobulin domain-containing protein 1; C3a; C3a anaphylatoxin; C3adesArg; C3b; C3bc; C3-beta-c; C3r1; Complement C3; complement C3 alpha chain; Complement C3 beta chain; complement C3 protein (GPC3) precursor; Complement C3b alpha' chain; Complement C3c alpha' chain fragment 1; Complement C3c alpha' chain fragment 2; Complement C3d fragment; Complement C3dg fragment; Complement C3f fragment; Complement C3g fragment; complement component 3; complement component C3 alpha-chain; complement component C3a; complement component C3b; CPAMD1; epididymis secretory sperm binding protein Li 62p; HEL-S-62p; HSE-MSF; Plp; prepro-C3 |
| Show More |
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.